In a recent study by Bild et al. [3], gene signatures of Myc, Ras, E2F3, Src, and beta-catenin defined in vitro were used to predict Ras mutation status in human lung tumors and to predict the response of a panel of breast cancer cell lines to Src or Ras inhibitors. The gene discussed is SRC; the disease is breast cancer.